Avonex ® pen is now available in Spain for the treatment of multiple sclerosis
[if gte mso 9] > < xml > normal 0 21 false false false MicrosoftInternetExplorer4 <!-[if gte mso 9] > < w:LatentStyles DefLockedState = “false” LatentStyleCount = “156” > <!-[if! mso] > <!-[if gte mso 10] > Avonex ® pen is now available in Spain for treatmentof multiple sclerosis -Avonex Pen ® is the first IM autoinyector for the treatment of sclerosisMultiple, weekly to improve the comfort of therapy and therefore its qualitylife Madrid, June 2012. – Avonex Pen ®, the new format of thedrug for the treatment of the sclerosis multiple Avonex ® (interferon)(beta-1a), is already available in Spain Avonex Pen ® is the first autoinyectorintramuscular weekly, disposable and easy to apply, which improves thecomfort of therapy this treatment, and consequently, their adherenceand their quality of life. Avonex ® (interferon beta-1a), Biogen Idec, is one of themost prescribed treatments around the world for the type of EMSender-Recidivante (RRMS), with more than 141.694 patients treated. It hasproven to be effective in decreasing the inability, of the rate ofthe development of identified brain lesions and clinical recurrence byMagnetic resonance imaging (MRI). the new Pen Avonex ® device, is designed toalleviate the concerns associated with the administration of Avonex ®, as theanxiety by injection, needle phobia or the need for coordinationphysically the injection, making the completely autonomous patient. Avonex Pen ® integrates the pre-loaded syringe system ofAvonex ® with a 16...
Read More